Skip to main content
. 2022 Oct 27;19(10):e1003979. doi: 10.1371/journal.pmed.1003979

Fig 4. Severity of adverse events.

Fig 4

Severity of adverse events present in the 7 days after vaccination in people living with HIV, comparing mRNA (BNT162b2 and mRNA-1273) and vector (ChAdOx1-S and Ad26.COV2.S) vaccines, shown as percentage (%) of participants.